CINECA IRIS Institutional Research Information System

ZIBETTI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.962
EU - Europa 10.356
AS - Asia 8.815
SA - Sud America 1.488
AF - Africa 229
OC - Oceania 165
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.332
IT - Italia 3.744
SG - Singapore 3.106
CN - Cina 2.416
BR - Brasile 1.139
DE - Germania 968
FR - Francia 928
VN - Vietnam 841
IE - Irlanda 756
SE - Svezia 748
GB - Regno Unito 545
FI - Finlandia 502
JP - Giappone 480
CA - Canada 432
IN - India 342
AT - Austria 316
ES - Italia 312
NL - Olanda 304
KR - Corea 303
HK - Hong Kong 298
PL - Polonia 204
UA - Ucraina 194
BD - Bangladesh 147
TR - Turchia 147
AU - Australia 144
TW - Taiwan 144
AR - Argentina 142
BE - Belgio 138
MX - Messico 113
ID - Indonesia 107
PT - Portogallo 105
CH - Svizzera 82
GR - Grecia 78
RU - Federazione Russa 78
DK - Danimarca 71
IQ - Iraq 71
ZA - Sudafrica 61
CO - Colombia 54
RO - Romania 50
PK - Pakistan 49
CL - Cile 39
UZ - Uzbekistan 39
EG - Egitto 37
IL - Israele 37
EC - Ecuador 36
SA - Arabia Saudita 35
TH - Thailandia 32
BG - Bulgaria 30
MA - Marocco 30
PE - Perù 30
CZ - Repubblica Ceca 29
IR - Iran 27
JM - Giamaica 25
PH - Filippine 25
MY - Malesia 23
AE - Emirati Arabi Uniti 21
NZ - Nuova Zelanda 20
NO - Norvegia 19
NG - Nigeria 18
RS - Serbia 18
SI - Slovenia 18
TN - Tunisia 18
PY - Paraguay 17
NP - Nepal 16
VE - Venezuela 16
HR - Croazia 15
KE - Kenya 14
LT - Lituania 14
SK - Slovacchia (Repubblica Slovacca) 14
JO - Giordania 13
LB - Libano 12
OM - Oman 12
CR - Costa Rica 11
LV - Lettonia 11
SN - Senegal 11
UY - Uruguay 11
DZ - Algeria 10
HU - Ungheria 10
AL - Albania 9
HN - Honduras 9
IS - Islanda 9
LU - Lussemburgo 9
SV - El Salvador 9
BY - Bielorussia 8
EE - Estonia 8
KZ - Kazakistan 8
NI - Nicaragua 8
AZ - Azerbaigian 7
GE - Georgia 7
SY - Repubblica araba siriana 7
CI - Costa d'Avorio 6
CY - Cipro 6
ET - Etiopia 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
MD - Moldavia 5
AM - Armenia 4
BO - Bolivia 4
GH - Ghana 4
KW - Kuwait 4
Totale 36.951
Salva come PNG Salva come JPEG
Città #
Singapore 1.780
Chandler 1.273
San Jose 1.227
Ashburn 1.054
Beijing 1.049
Santa Clara 872
Dublin 736
Fairfield 509
Milan 460
Houston 446
Torino 429
Dallas 381
Ann Arbor 373
Redwood City 326
Nyköping 288
Wilmington 284
Villeurbanne 271
Turin 268
Princeton 258
Woodbridge 253
Los Angeles 252
Rome 246
Vienna 241
Medford 234
Seattle 234
Ho Chi Minh City 231
Columbus 223
Hong Kong 215
Lauterbourg 215
The Dalles 194
Cambridge 193
Helsinki 189
New York 180
Dearborn 177
Boston 171
Hanoi 171
Jacksonville 171
Warsaw 156
Tokyo 154
Buffalo 143
Munich 130
São Paulo 130
Pisa 122
Seoul 109
Guangzhou 106
Ottawa 106
Shanghai 98
Hefei 97
Boardman 86
Dong Ket 83
Taipei 82
Frankfurt am Main 79
Madrid 75
London 71
Jakarta 69
Amsterdam 68
Chicago 67
Fremont 64
Toronto 64
Nanjing 63
Brussels 62
Orem 60
Naples 59
Bologna 55
Council Bluffs 51
Chengdu 49
Phoenix 49
Washington 48
Düsseldorf 46
Hangzhou 46
Verona 46
Paris 45
Redondo Beach 44
Turku 43
Istanbul 42
Atlanta 41
Rio de Janeiro 41
Montreal 40
Nuremberg 40
Bengaluru 39
Wuhan 38
Belo Horizonte 37
Lisbon 37
Brooklyn 36
Da Nang 36
Hebei 35
Johannesburg 35
San Diego 35
Collegno 34
Norwalk 33
Chennai 32
Mumbai 32
Palermo 32
Berlin 31
Florence 31
Denver 30
Santiago 30
Sydney 30
Barcelona 29
Haiphong 29
Totale 19.904
Salva come PNG Salva come JPEG
Nome #
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study 1.831
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. 1.091
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 920
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 849
Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy 784
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 773
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review 758
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 642
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 544
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 536
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 483
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 429
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder 426
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 394
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 377
Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification 370
Gut microbiota and metabolome distinctive features in parkinson disease: Focus on levodopa and levodopa carbidopa intrajejunal gel 352
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 346
Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease. 334
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 327
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 288
Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation 285
Teaching neurons to respond to placebos 282
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. 272
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 242
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study 236
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 229
Stimulation of the subthalamic area modulating movement and behavior 222
Neurological comorbidity and severity of COVID-19 222
Impulsivities and Parkinson's disease: Delay aversion is not worsened by Deep Brain Stimulation of the Subthalamic Nucleus 218
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 201
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response 193
Narrative abilities in Parkinson's disease:A pilot study on italian-speaking patients treated with deep brain stimulation of the subthalamic nucleus 183
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age 179
Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial 179
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 177
Sleep microstructure in Parkinson's disease: cycling alternating pattern (CAP) as a sensitive marker of early NREM sleep instability 176
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 174
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 174
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 173
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 173
Assessing rem sleep behaviour disorder: From machine learning classification to the definition of a continuous dissociation index 173
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 172
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 169
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 169
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation 168
ARGUMENTS IN FAVOUR OF AN EARLIER APPLICATION OF STN-DBS IN THE COURSE OF PARKINSON DISEASE. 166
Apathy and verbal fluency in STN-stimulated PD patients 165
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 164
AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION 162
Unawareness of dyskinesias in Parkinson’s Disease: Is there a relationship with Theory of Mind dysfunctions? 162
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 161
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 159
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study 156
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 154
Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study 153
Dysphagia predicts poor outcome in late-stage Parkinson's disease 152
Macro- and Micro-Structural Aspects of Sleep in Severe Parkinson's Disease 152
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 151
3 years comparison between duodopa and Deep Brain Stimulation 151
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 151
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. 148
Advanced therapies in Parkinson's disease: Long-term retrospective study 147
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies 147
Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits 145
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning 144
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 143
Effects of subthalamic stimulation on brain electrical activity during a motor task in Parkinson's disease 143
The relationship between cerebral vascular disease and parkinsonism: The VADO study. 142
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 140
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 140
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI piloting study 139
Comparison of subthalamic nucleus Deep Brain Stimulation and Duodopa in the treatment of advanced Parkinson's disease. 138
A new index to assess turning quality and postural stability in patients with Parkinson's disease 137
Diagnosing REM sleep behavior disorder in Parkinson’s disease without a gold standard: a latent-class model study 136
Validation of the Italian version of the PSP Quality of Life questionnaire 136
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 135
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 134
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 134
COVID-19 in Parkinson's disease: Report on prevalence and outcome 134
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 134
Valutazione dei cicli masticatori discinetici in pazienti affetti da morbo di Parkinson in fase avanzata con e senza terapia medica. 133
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 133
Analysis of Sleep Pattern after Duodenal Levodopa Infusion in Advanced Parkinson’s Disease 133
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress 132
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review 132
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 130
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 129
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 127
“ Effetti cognitivo comportamentali della dbs del subtalamo in pazienti parkinsoniani: follow-up a 5 anni” 126
Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease 126
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 126
Fisiopatologia della masticazione nei pazienti affetti da malattia di Parkinson trattati farmacologicamente e sottoposti a stimolazione cerebrale preofonda. 125
NADPH oxidases 2 activation in patients with Parkinson's disease 125
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 125
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 124
Deep brain stimulation in Parkinson's disease: A multicentric, long-term, observational pilot study 124
Is REM sleep behavior disorder associated with a less favorable outcome of STN-DBS in PD? 123
COVID-19 and Parkinson's Disease: What We Know So Far? 123
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease 122
Totale 25.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.548
article - articoli 0
book - libri 0
conference - conferenze 17.965
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.902 149 111 115 290 150 144 173 150 127 203 694 596
2022/20234.170 442 380 140 393 365 941 297 287 406 145 242 132
2023/20242.208 247 333 121 127 191 249 90 165 43 149 201 292
2024/20255.731 150 326 219 505 1.281 443 298 349 553 387 483 737
2025/202611.548 1.009 434 870 1.106 1.171 561 1.469 496 846 1.198 570 1.818
2026/2027222 222 0 0 0 0 0 0 0 0 0 0 0
Totale 37.860